Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;36(3):391-416.
doi: 10.1007/s10534-022-00453-x. Epub 2022 Oct 10.

Lactoferrin: from the structure to the functional orchestration of iron homeostasis

Affiliations
Review

Lactoferrin: from the structure to the functional orchestration of iron homeostasis

Giusi Ianiro et al. Biometals. 2023 Jun.

Abstract

Iron is by far the most widespread and essential transition metal, possessing crucial biological functions for living systems. Despite chemical advantages, iron biology has forced organisms to face with some issues: ferric iron insolubility and ferrous-driven formation of toxic radicals. For these reasons, acquisition and transport of iron constitutes a formidable challenge for cells and organisms, which need to maintain adequate iron concentrations within a narrow range, allowing biological processes without triggering toxic effects. Higher organisms have evolved extracellular carrier proteins to acquire, transport and manage iron. In recent years, a renewed interest in iron biology has highlighted the role of iron-proteins dysregulation in the onset and/or exacerbation of different pathological conditions. However, to date, no resolutive therapy for iron disorders has been found. In this review, we outline the efficacy of Lactoferrin, a member of the transferrin family mainly secreted by exocrine glands and neutrophils, as a new emerging orchestrator of iron metabolism and homeostasis, able to counteract iron disorders associated to different pathologies, including iron deficiency and anemia of inflammation in blood, Parkinson and Alzheimer diseases in the brain and cystic fibrosis in the lung.

Keywords: Anemia of inflammation; Brain iron; Iron homeostasis; Lactoferrin; Lung iron; Transferrin.

PubMed Disclaimer

References

    1. Aali M, Caldwell A, House K, Zhou J, Chappe V, Lehmann C (2017) Iron chelation as novel treatment for lung inflammation in cystic fibrosis. Med Hypotheses 104:86–88. https://doi.org/10.1016/j.mehy.2017.05.029 - DOI - PubMed
    1. Abbott NJ (2002) Astrocyte–endothelial interactions and blood–brain barrier permeability. J Anat 200:629–638. https://doi.org/10.1046/j.1469-7580.2002.00064.x - DOI - PubMed - PMC
    1. Agoro R, Mura C (2019) Iron supplementation therapy, a friend and foe of mycobacterial infections? Pharmaceuticals (basel) 12:75. https://doi.org/10.3390/ph12020075 - DOI - PubMed
    1. Ali MK, Kim RY, Karim R, Mayall JR, Martin KL, Shahandeh A, Abbasian F, Starkey MR, Loustaud-Ratti V, Johnstone D, Milward EA, Hansbro PM, Horvat JC (2017) Role of iron in the pathogenesis of respiratory disease. Int J Biochem Cell Biol 88:181–195. https://doi.org/10.1016/j.biocel.2017.05.003 - DOI - PubMed
    1. Altamura S, Muckenthaler MU (2009) Iron toxicity in diseases of aging: Alzheimer’s disease, Parkinson’s disease and atherosclerosis. J Alzheimers Dis 16:879–895. https://doi.org/10.3233/JAD-2009-1010 - DOI - PubMed

LinkOut - more resources